Eli Lilly (LLY) Stock on December 1, 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Outlook
As of December 1, 2025, Eli Lilly and Company (NYSE: LLY) is trading around $1,075 per share, giving the drugmaker a market capitalization of roughly $1.0–1.02 trillion and cementing its status as the first pharmaceutical company to enter the trillion‑dollar club. MarketBeat+1 But today’s story is not just about the share price. Fresh Zepbound price cuts, new World Health Organization (WHO) guidance on GLP‑1 obesity drugs, and ongoing debate over valuation vs. growth are shaping how investors look at Eli Lilly stock heading into 2026. Below is a detailed, news‑driven look at LLY stock on December 1, 2025, including the